This Pulmonary Drug Delivery market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply chain dynamics, and insights about new geographical markets. The market insights covered in Pulmonary Drug Delivery report simplifies managing marketing of goods and services effectively.
Data Bridge Market Research analyses that the pulmonary drug delivery market, valued at USD 47.85 billion in 2022, will reach USD 72.88 billion by 2030, growing at a CAGR of 5.4% during the forecast period of 2023 to 2030
Download Sample PDF Copy of this Report to understand structure of the complete report @
Market Overview:
The primary goal of the drug delivery route, known as pulmonary drug delivery, is to deposit inhaled pharmacological agents in lower airways with devices that assist with inhaling drug formulations through the mouth. They are extensively used in various end-user industries, including hospitals, clinics, and home care settings. Numerous devices are used for respiratory delivery, including nebulizers, metered-dose inhalers, and dry powder inhalers. Inhaled beta-agonists, corticosteroids, and anticholinergic medications are delivered through the lungs to treat asthma and chronic obstructive pulmonary disease (COPD). The pulmonary administration route has several advantages. The medication is administered right to the disease site to treat respiratory diseases.
Some of the major players operating in the Pulmonary Drug Delivery market are F. Hoffmann-La Roche Ltd (Switzerland), MannKind Corporation (U.S.), OMRON Healthcare, Inc. (Japan), Mylan N.V (U.S.), 3M (U.S.), Koninklijke Philips N.V. (Netherlands), Merck & Co., Inc., (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sunovion Pharmaceuticals Inc. (U.S.), PARI GmbH (Germany), Jabil Inc. (U.S.), AstraZeneca (U.K.), Boehringer Ingelheim International GmbH. (Germany), GSK plc. (U.K.), Novartis AG (Switzerland), Aerogen Pharma (Irland), Briggs Healthcare (U.S.), HAAG-STREIT GROUP (Switzerland), Janssen Global Services, LLC (U.S.), AptarGroup, Inc. (U.S.) among others.
Global Pulmonary Drug Delivery Market Scope
The pulmonary drug delivery market is segmented on the basis of formulations, canister type, application, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Formulations
- Type
- Suspension aerosol
- Solution Aerosal
- Dry power formulation
- Device type
- Dry Powder Inhalers
- Single-Dose Inhalers
- Multi-Dose Inhaler
- Metered Dose Inhalers
- Manually-Actuated Pressurized Inhaler
- Breath-Actuated Pressurized Inhaler
- Nebulizers
- Jet Nebulizers
- Soft Mist Nebulizers
- Ultra Wave Nebulizers
- Mesh
- Vibrating
- Static
- Pneumatic
- Vented
- Breath Actuated
- Accessories
Canister Type
- Plain Canister
- Coated Canister
Application
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Cystic Fibrosis
- Allergic Rhinitis
- Other
End-User
- Hospitals and Clinics
- Home Care Settings
Browse More About This Research Report @ https://www.databridgemarketresearch.com/reports/global-pulmonary-drug-delivery-market
Table of Content:
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Global Pulmonary Drug Delivery Market Landscape
Part 04: Global Pulmonary Drug Delivery Market Sizing
Part 05: Global Pulmonary Drug Delivery Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Browse Trending Reports:
Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market
https://www.databridgemarketresearch.com/reports/global-vascular-endothelial-growth-factor-vegf-inhibitor-market
Global Unmanned Marine Vehicles Market
https://www.databridgemarketresearch.com/reports/global-unmanned-marine-vehicles-market
Global Cancer Biological Therapy Market
https://www.databridgemarketresearch.com/reports/global-cancer-biological-therapy-market
Global Athlete′s Foot Drugs Market
https://www.databridgemarketresearch.com/reports/global-athletes-foot-drugs-market
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: – [email protected]